Next, to assess the relevance of these changes to the human disease, we transplanted human primary FLT3-ITD+ AML blasts into NSG-SGM3 (NSGS) mice and generated a patient-derived xenograft (PDX) model. The gene discussed is FLT3; the disease is acute myeloid leukemia.